INIST ST CO., LTD

About INIST ST CO., LTD

Since 2000, INIST ST has headed developing raw material medicine and its synthesis technology. Based on change and innovation, and love for life, INIST ST has researched and developed excellent-quality generic raw materials and new salt IMDs (incrementally modified drug) starting from cerebrovascular medicine and has supplied them domestically and overseas. 
INIST’s products show high demand for generic APIs in domestic market, yet overseas sales is also steadily increasing. Now, we are aiming to expand overseas sales, targeting USA, Europe, Middle East, etc. 

Certifications
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer
Contact info
Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026

CPHI Korea 2026

COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026

Products from INIST ST CO., LTD (11)